Absent X‐linked inhibitor of apoptosis protein expression in T cell blasts and causal mutations including non‐coding deletion
Authors:
- 1 January 2022
- journal article
- research article
- Published by Wiley in Pediatrics International
- Vol. 64 (1)
Abstract
Background: X‐linked inhibitor of apoptosis protein (XIAP) deficiency is one of inborn errors of immunity characterized by recurrent hemophagocytic lymphohistiocytosis and refractory inflammatory bowel disease (IBD), mimicking Crohn’s disease. The aim of this study is to make an accurate diagnosis of XIAP deficiency based on genetic and XIAP expression studies and to investigate endoscopic findings shared by patients with this disease. Methods: Four male patients with recurrent hemophagocytic lymphohistiocytosis and long‐term refractory IBD were studied for the diagnosis of XIAP deficiency. Endoscopic findings of the four patients were also studied in parallel. Results: These four patients were diagnosed with XIAP deficiency based on the absent XIAP expression in cultured T‐cell blasts. Sequence analysis of the responsible gene, XIAP , demonstrated two novel nonsense mutations of p.Gln114X and p.Glu25X, and a previously reported nonsense mutation of p.Arg381X. Although no mutations in the coding region were detected in the fourth patient, further studies demonstrated a novel 2,199 bp deletion encompassing non‐coding exon 1, presumably affecting transcription and stability of XIAP mRNA. All of the patients eventually underwent hematopoietic stem cell transplantation, leading to a complete or partial remission of IBD. These four patients shared an endoscopic finding of multiple wide and longitudinal ulcers with straight and non‐raised edge in the colon. Conclusions: X‐linked inhibitor of apoptosis protein expression in T‐cell blasts could facilitate the diagnosis of this disease, especially with causal mutations in non‐coding regions.Keywords
This publication has 17 references indexed in Scilit:
- Long‐term therapeutic effectiveness of maintenance enteral nutrition for Crohn's diseasePediatrics International, 2015
- Characterization of Crohn disease in X-linked inhibitor of apoptosis–deficient male patients and female symptomatic carriersJournal of Allergy and Clinical Immunology, 2014
- XIAP variants in male Crohn's diseaseGut, 2014
- X-linked inhibitor of apoptosis (XIAP) deficiency: The spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosisClinical Immunology, 2013
- Somatic mosaicism in two unrelated patients with X-linked chronic granulomatous disease characterized by the presence of a small population of normal cellsGene, 2012
- Pediatric modification of the Montreal classification for inflammatory bowel diseaseInflammatory Bowel Diseases, 2011
- Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)Blood, 2011
- Determination of the deletion breakpoints in two patients with contiguous gene syndrome encompassing CYBB geneEuropean Journal of Medical Genetics, 2010
- XIAP mediates NOD signaling via interaction with RIP2Proceedings of the National Academy of Sciences, 2009
- XIAP deficiency in humans causes an X-linked lymphoproliferative syndromeNature, 2006